JOHANNESBURG – One of the world's leading medical cannabis research and production companies has begun exporting medical cannabis products to South Africa, in partnership with local biotechnology firm BGM Pharmaceuticals.
Last week, Tilray, which is based in Canada, announced it had "successfully exported medical cannabis products to South Africa for nationwide distribution to qualified patients through pharmacies."
Tilray chief executive Brendan Kennedy: “We are encouraged by the evolving regulations pertaining to cannabis in South Africa and around the world and are pleased to make our pharmaceutical-grade products available to qualified patients in need in throughout the country.”
One of BGM's other projects is a R600 million partnership with energy corporation Necsa and the University of Cape Town to bring a cancer diagnostic system to market.
Top image: © EpicStockMedia | Adobe Stock